MSP Recovery, Inc. (NASDAQ: MSPRV) Stock Competitors & Peer Comparison
See MSPRV's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for MSPRV and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MSPRV | $0.07 | -11.57% | 0 | N/A | N/A | N/A |
| VEEV | $189.24 | -4.14% | 30.7B | 22.71 | $8.33 | N/A |
| GEHC | $62.04 | -1.26% | 28.2B | 13.61 | $4.56 | +0.23% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSGU | $239.04 | +3.24% | 14.4B | 216.59 | $1.11 | N/A |
| BTSG | $72.56 | +2.92% | 14.2B | 58.52 | $1.24 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| TEM | $48.98 | +1.18% | 8.5B | -97.96 | -$0.50 | N/A |
| HQY | $97.77 | -1.12% | 8.2B | 22.84 | $4.28 | N/A |
| HNGE | $84.35 | -3.82% | 6.5B | 43.22 | $1.95 | N/A |
Stock Comparison
Veeva Systems Inc. (NYSE: VEEV)
MSPRV vs VEEV Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, VEEV has a market cap of 30.7B. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while VEEV trades at $189.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas VEEV's P/E ratio is 22.71. In terms of profitability, MSPRV's ROE is N/A, compared to VEEV's ROE of +0.13%. Regarding short-term risk, MSPRV is more volatile compared to VEEV. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check VEEV's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
MSPRV vs GEHC Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, GEHC has a market cap of 28.2B. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while GEHC trades at $62.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas GEHC's P/E ratio is 13.61. In terms of profitability, MSPRV's ROE is N/A, compared to GEHC's ROE of +0.15%. Regarding short-term risk, MSPRV is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check GEHC's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
MSPRV vs GEHCV Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas GEHCV's P/E ratio is N/A. In terms of profitability, MSPRV's ROE is N/A, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, MSPRV is more volatile compared to GEHCV. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check GEHCV's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
MSPRV vs BTSGU Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, BTSGU has a market cap of 14.4B. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while BTSGU trades at $239.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas BTSGU's P/E ratio is 216.59. In terms of profitability, MSPRV's ROE is N/A, compared to BTSGU's ROE of +0.17%. Regarding short-term risk, MSPRV is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check BTSGU's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
MSPRV vs BTSG Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, BTSG has a market cap of 14.2B. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while BTSG trades at $72.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas BTSG's P/E ratio is 58.52. In terms of profitability, MSPRV's ROE is N/A, compared to BTSG's ROE of +0.17%. Regarding short-term risk, MSPRV is more volatile compared to BTSG. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check BTSG's competition here
Signify Health, Inc. (NYSE: SGFY)
MSPRV vs SGFY Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas SGFY's P/E ratio is 70.91. In terms of profitability, MSPRV's ROE is N/A, compared to SGFY's ROE of -0.15%. Regarding short-term risk, MSPRV is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check SGFY's competition here
Tempus AI, Inc. (NASDAQ: TEM)
MSPRV vs TEM Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, TEM has a market cap of 8.5B. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while TEM trades at $48.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas TEM's P/E ratio is -97.96. In terms of profitability, MSPRV's ROE is N/A, compared to TEM's ROE of -0.70%. Regarding short-term risk, MSPRV is more volatile compared to TEM. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check TEM's competition here
HealthEquity, Inc. (NASDAQ: HQY)
MSPRV vs HQY Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, HQY has a market cap of 8.2B. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while HQY trades at $97.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas HQY's P/E ratio is 22.84. In terms of profitability, MSPRV's ROE is N/A, compared to HQY's ROE of +0.11%. Regarding short-term risk, MSPRV is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check HQY's competition here
Hinge Health, Inc. (NYSE: HNGE)
MSPRV vs HNGE Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, HNGE has a market cap of 6.5B. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while HNGE trades at $84.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas HNGE's P/E ratio is 43.22. In terms of profitability, MSPRV's ROE is N/A, compared to HNGE's ROE of -1.39%. Regarding short-term risk, MSPRV is more volatile compared to HNGE. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check HNGE's competition here
R1 RCM Inc. (NASDAQ: RCM)
MSPRV vs RCM Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, RCM has a market cap of 6B. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas RCM's P/E ratio is -102.21. In terms of profitability, MSPRV's ROE is N/A, compared to RCM's ROE of +0.00%. Regarding short-term risk, MSPRV is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check RCM's competition here
10x Genomics, Inc. (NASDAQ: TXG)
MSPRV vs TXG Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, TXG has a market cap of 6B. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while TXG trades at $47.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas TXG's P/E ratio is -277.65. In terms of profitability, MSPRV's ROE is N/A, compared to TXG's ROE of -0.03%. Regarding short-term risk, MSPRV is more volatile compared to TXG. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check TXG's competition here
Doximity, Inc. (NYSE: DOCS)
MSPRV vs DOCS Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, DOCS has a market cap of 3.9B. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while DOCS trades at $21.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas DOCS's P/E ratio is 13.79. In terms of profitability, MSPRV's ROE is N/A, compared to DOCS's ROE of +0.19%. Regarding short-term risk, MSPRV is more volatile compared to DOCS. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check DOCS's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
MSPRV vs ONEM Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas ONEM's P/E ratio is -7.77. In terms of profitability, MSPRV's ROE is N/A, compared to ONEM's ROE of -0.24%. Regarding short-term risk, MSPRV is more volatile compared to ONEM. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
MSPRV vs PRVA Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, PRVA has a market cap of 3.3B. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while PRVA trades at $26.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas PRVA's P/E ratio is 164.44. In terms of profitability, MSPRV's ROE is N/A, compared to PRVA's ROE of +0.03%. Regarding short-term risk, MSPRV is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check PRVA's competition here
Progyny, Inc. (NASDAQ: PGNY)
MSPRV vs PGNY Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, PGNY has a market cap of 2.5B. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while PGNY trades at $32.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas PGNY's P/E ratio is 23.53. In terms of profitability, MSPRV's ROE is N/A, compared to PGNY's ROE of +0.13%. Regarding short-term risk, MSPRV is more volatile compared to PGNY. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check PGNY's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
MSPRV vs HTFL Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, HTFL has a market cap of 2.2B. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while HTFL trades at $25.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas HTFL's P/E ratio is -12.66. In terms of profitability, MSPRV's ROE is N/A, compared to HTFL's ROE of +8.30%. Regarding short-term risk, MSPRV is more volatile compared to HTFL. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check HTFL's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
MSPRV vs WGS Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, WGS has a market cap of 1.8B. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while WGS trades at $61.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas WGS's P/E ratio is 72.53. In terms of profitability, MSPRV's ROE is N/A, compared to WGS's ROE of -0.28%. Regarding short-term risk, MSPRV is more volatile compared to WGS. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check WGS's competition here
Teladoc Health, Inc. (NYSE: TDOC)
MSPRV vs TDOC Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, TDOC has a market cap of 1.8B. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while TDOC trades at $9.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas TDOC's P/E ratio is -10.79. In terms of profitability, MSPRV's ROE is N/A, compared to TDOC's ROE of -0.12%. Regarding short-term risk, MSPRV is more volatile compared to TDOC. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check TDOC's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
MSPRV vs NXGN Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas NXGN's P/E ratio is -266.00. In terms of profitability, MSPRV's ROE is N/A, compared to NXGN's ROE of -0.01%. Regarding short-term risk, MSPRV is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check NXGN's competition here
Agiliti, Inc. (NYSE: AGTI)
MSPRV vs AGTI Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas AGTI's P/E ratio is -71.79. In terms of profitability, MSPRV's ROE is N/A, compared to AGTI's ROE of -0.02%. Regarding short-term risk, MSPRV is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check AGTI's competition here
Omada Health (NASDAQ: OMDA)
MSPRV vs OMDA Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while OMDA trades at $22.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas OMDA's P/E ratio is 328.43. In terms of profitability, MSPRV's ROE is N/A, compared to OMDA's ROE of -0.03%. Regarding short-term risk, MSPRV is more volatile compared to OMDA. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check OMDA's competition here
Certara, Inc. (NASDAQ: CERT)
MSPRV vs CERT Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, CERT has a market cap of 1.1B. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while CERT trades at $6.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas CERT's P/E ratio is 17.56. In terms of profitability, MSPRV's ROE is N/A, compared to CERT's ROE of -0.01%. Regarding short-term risk, MSPRV is more volatile compared to CERT. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check CERT's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
MSPRV vs GDRX Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, GDRX has a market cap of 1B. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while GDRX trades at $3.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas GDRX's P/E ratio is 9.15. In terms of profitability, MSPRV's ROE is N/A, compared to GDRX's ROE of +0.03%. Regarding short-term risk, MSPRV is more volatile compared to GDRX. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check GDRX's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
MSPRV vs CCLDO Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas CCLDO's P/E ratio is N/A. In terms of profitability, MSPRV's ROE is N/A, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, MSPRV is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check CCLDO's competition here
HealthStream, Inc. (NASDAQ: HSTM)
MSPRV vs HSTM Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, HSTM has a market cap of 813.4M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while HSTM trades at $27.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas HSTM's P/E ratio is 36.63. In terms of profitability, MSPRV's ROE is N/A, compared to HSTM's ROE of +0.06%. Regarding short-term risk, MSPRV is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check HSTM's competition here
Evolent Health, Inc. (NYSE: EVH)
MSPRV vs EVH Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, EVH has a market cap of 656.9M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while EVH trades at $5.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas EVH's P/E ratio is 584.00. In terms of profitability, MSPRV's ROE is N/A, compared to EVH's ROE of -0.78%. Regarding short-term risk, MSPRV is more volatile compared to EVH. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check EVH's competition here
Phreesia, Inc. (NYSE: PHR)
MSPRV vs PHR Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, PHR has a market cap of 654.6M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while PHR trades at $10.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas PHR's P/E ratio is 37.82. In terms of profitability, MSPRV's ROE is N/A, compared to PHR's ROE of +0.03%. Regarding short-term risk, MSPRV is more volatile compared to PHR. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check PHR's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
MSPRV vs MPLN-WT Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, MSPRV's ROE is N/A, compared to MPLN-WT's ROE of +2.06%. Regarding short-term risk, MSPRV is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for MSPRV.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
MSPRV vs ACCD Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas ACCD's P/E ratio is -3.08. In terms of profitability, MSPRV's ROE is N/A, compared to ACCD's ROE of -0.22%. Regarding short-term risk, MSPRV is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
MSPRV vs SHCR Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas SHCR's P/E ratio is -3.76. In terms of profitability, MSPRV's ROE is N/A, compared to SHCR's ROE of -0.25%. Regarding short-term risk, MSPRV is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check SHCR's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
MSPRV vs WGSWW Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, WGSWW has a market cap of 514.5M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas WGSWW's P/E ratio is N/A. In terms of profitability, MSPRV's ROE is N/A, compared to WGSWW's ROE of -0.28%. Regarding short-term risk, MSPRV is less volatile compared to WGSWW. This indicates lower risk in terms of short-term price fluctuations for MSPRV.Check WGSWW's competition here
Claritev Corporation (NYSE: CTEV)
MSPRV vs CTEV Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, CTEV has a market cap of 488.4M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while CTEV trades at $28.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas CTEV's P/E ratio is -2.20. In terms of profitability, MSPRV's ROE is N/A, compared to CTEV's ROE of +2.06%. Regarding short-term risk, MSPRV is more volatile compared to CTEV. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check CTEV's competition here
NRC Health (NASDAQ: NRC)
MSPRV vs NRC Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, NRC has a market cap of 484.1M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while NRC trades at $21.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas NRC's P/E ratio is 26.20. In terms of profitability, MSPRV's ROE is N/A, compared to NRC's ROE of +0.57%. Regarding short-term risk, MSPRV is more volatile compared to NRC. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check NRC's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
MSPRV vs SOPH Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, SOPH has a market cap of 446.8M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while SOPH trades at $6.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas SOPH's P/E ratio is -12.50. In terms of profitability, MSPRV's ROE is N/A, compared to SOPH's ROE of -1.41%. Regarding short-term risk, MSPRV is more volatile compared to SOPH. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check SOPH's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
MSPRV vs SLGCW Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, MSPRV's ROE is N/A, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, MSPRV is more volatile compared to SLGCW. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check SLGCW's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
MSPRV vs SLGC Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas SLGC's P/E ratio is -3.04. In terms of profitability, MSPRV's ROE is N/A, compared to SLGC's ROE of -0.19%. Regarding short-term risk, MSPRV is more volatile compared to SLGC. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check SLGC's competition here
TruBridge, Inc. (NASDAQ: TBRG)
MSPRV vs TBRG Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas TBRG's P/E ratio is 9.37. In terms of profitability, MSPRV's ROE is N/A, compared to TBRG's ROE of +0.02%. Regarding short-term risk, MSPRV is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
MSPRV vs MPLN Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas MPLN's P/E ratio is -0.23. In terms of profitability, MSPRV's ROE is N/A, compared to MPLN's ROE of +2.06%. Regarding short-term risk, MSPRV is more volatile compared to MPLN. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check MPLN's competition here
Simulations Plus, Inc. (NASDAQ: SLP)
MSPRV vs SLP Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, SLP has a market cap of 368.7M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while SLP trades at $18.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas SLP's P/E ratio is 20.72. In terms of profitability, MSPRV's ROE is N/A, compared to SLP's ROE of +0.06%. Regarding short-term risk, MSPRV is more volatile compared to SLP. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check SLP's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
MSPRV vs TRHC Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas TRHC's P/E ratio is -4.27. In terms of profitability, MSPRV's ROE is N/A, compared to TRHC's ROE of +121.31%. Regarding short-term risk, MSPRV is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
MSPRV vs SMFR Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas SMFR's P/E ratio is N/A. In terms of profitability, MSPRV's ROE is N/A, compared to SMFR's ROE of -0.28%. Regarding short-term risk, MSPRV is more volatile compared to SMFR. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check SMFR's competition here
So-Young International Inc. (NASDAQ: SY)
MSPRV vs SY Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, SY has a market cap of 240.1M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while SY trades at $1.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas SY's P/E ratio is -5.55. In terms of profitability, MSPRV's ROE is N/A, compared to SY's ROE of -0.16%. Regarding short-term risk, MSPRV is more volatile compared to SY. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check SY's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
MSPRV vs SPOK Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, SPOK has a market cap of 222.7M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while SPOK trades at $10.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas SPOK's P/E ratio is 17.77. In terms of profitability, MSPRV's ROE is N/A, compared to SPOK's ROE of +0.09%. Regarding short-term risk, MSPRV is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check SPOK's competition here
American Well Corporation (NYSE: AMWL)
MSPRV vs AMWL Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, AMWL has a market cap of 209M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while AMWL trades at $12.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas AMWL's P/E ratio is -2.41. In terms of profitability, MSPRV's ROE is N/A, compared to AMWL's ROE of -0.35%. Regarding short-term risk, MSPRV is more volatile compared to AMWL. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check AMWL's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
MSPRV vs HCAT Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, HCAT has a market cap of 159.6M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while HCAT trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas HCAT's P/E ratio is 10.80. In terms of profitability, MSPRV's ROE is N/A, compared to HCAT's ROE of -1.00%. Regarding short-term risk, MSPRV is more volatile compared to HCAT. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check HCAT's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
MSPRV vs CPSI Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas CPSI's P/E ratio is -183.80. In terms of profitability, MSPRV's ROE is N/A, compared to CPSI's ROE of +0.02%. Regarding short-term risk, MSPRV is more volatile compared to CPSI. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check CPSI's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
MSPRV vs OPRX Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, OPRX has a market cap of 125M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while OPRX trades at $6.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas OPRX's P/E ratio is 6.11. In terms of profitability, MSPRV's ROE is N/A, compared to OPRX's ROE of +0.05%. Regarding short-term risk, MSPRV is more volatile compared to OPRX. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check OPRX's competition here
Augmedix, Inc. (NASDAQ: AUGX)
MSPRV vs AUGX Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas AUGX's P/E ratio is -4.99. In terms of profitability, MSPRV's ROE is N/A, compared to AUGX's ROE of -1.55%. Regarding short-term risk, MSPRV is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check AUGX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
MSPRV vs CCLD Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, CCLD has a market cap of 94.8M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while CCLD trades at $2.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas CCLD's P/E ratio is 8.26. In terms of profitability, MSPRV's ROE is N/A, compared to CCLD's ROE of +0.17%. Regarding short-term risk, MSPRV is more volatile compared to CCLD. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check CCLD's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
MSPRV vs DH Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, DH has a market cap of 76.5M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while DH trades at $0.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas DH's P/E ratio is 2.79. In terms of profitability, MSPRV's ROE is N/A, compared to DH's ROE of -0.67%. Regarding short-term risk, MSPRV is more volatile compared to DH. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check DH's competition here
Forian Inc. (NASDAQ: FORA)
MSPRV vs FORA Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas FORA's P/E ratio is -24.11. In terms of profitability, MSPRV's ROE is N/A, compared to FORA's ROE of -0.17%. Regarding short-term risk, MSPRV is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
MSPRV vs CCLDP Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas CCLDP's P/E ratio is N/A. In terms of profitability, MSPRV's ROE is N/A, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, MSPRV is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check CCLDP's competition here
OneMedNet Corporation (NASDAQ: ONMD)
MSPRV vs ONMD Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, ONMD has a market cap of 37.2M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while ONMD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas ONMD's P/E ratio is -4.36. In terms of profitability, MSPRV's ROE is N/A, compared to ONMD's ROE of +0.90%. Regarding short-term risk, MSPRV is more volatile compared to ONMD. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check ONMD's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
MSPRV vs SNCE Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas SNCE's P/E ratio is -0.27. In terms of profitability, MSPRV's ROE is N/A, compared to SNCE's ROE of -0.47%. Regarding short-term risk, MSPRV is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
MSPRV vs AKLI Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas AKLI's P/E ratio is -0.71. In terms of profitability, MSPRV's ROE is N/A, compared to AKLI's ROE of -0.70%. Regarding short-term risk, MSPRV is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
MSPRV vs SHLT Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas SHLT's P/E ratio is -3.87. In terms of profitability, MSPRV's ROE is N/A, compared to SHLT's ROE of -0.50%. Regarding short-term risk, MSPRV is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check SHLT's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
MSPRV vs ONMDW Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, ONMDW has a market cap of 33.2M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while ONMDW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas ONMDW's P/E ratio is N/A. In terms of profitability, MSPRV's ROE is N/A, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, MSPRV is more volatile compared to ONMDW. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check ONMDW's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
MSPRV vs SHCRW Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, MSPRV's ROE is N/A, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, MSPRV is more volatile compared to SHCRW. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check SHCRW's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
MSPRV vs EUDA Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, EUDA has a market cap of 26.8M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while EUDA trades at $15.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas EUDA's P/E ratio is -27.08. In terms of profitability, MSPRV's ROE is N/A, compared to EUDA's ROE of +0.70%. Regarding short-term risk, MSPRV is more volatile compared to EUDA. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check EUDA's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
MSPRV vs STRM Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas STRM's P/E ratio is -2.40. In terms of profitability, MSPRV's ROE is N/A, compared to STRM's ROE of -0.32%. Regarding short-term risk, MSPRV is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
MSPRV vs RNLX Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas RNLX's P/E ratio is -0.33. In terms of profitability, MSPRV's ROE is N/A, compared to RNLX's ROE of -6.31%. Regarding short-term risk, MSPRV is more volatile compared to RNLX. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
MSPRV vs LIFW Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas LIFW's P/E ratio is -0.02. In terms of profitability, MSPRV's ROE is N/A, compared to LIFW's ROE of +1.56%. Regarding short-term risk, MSPRV is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check LIFW's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
MSPRV vs BEATW Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, BEATW has a market cap of 18M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while BEATW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas BEATW's P/E ratio is -0.05. In terms of profitability, MSPRV's ROE is N/A, compared to BEATW's ROE of -10.34%. Regarding short-term risk, MSPRV is more volatile compared to BEATW. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check BEATW's competition here
Babylon Holdings Limited (NYSE: BBLN)
MSPRV vs BBLN Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas BBLN's P/E ratio is -0.04. In terms of profitability, MSPRV's ROE is N/A, compared to BBLN's ROE of +4.89%. Regarding short-term risk, MSPRV is more volatile compared to BBLN. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check BBLN's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
MSPRV vs ETAO Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas ETAO's P/E ratio is -0.01. In terms of profitability, MSPRV's ROE is N/A, compared to ETAO's ROE of -13.69%. Regarding short-term risk, MSPRV is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for MSPRV.Check ETAO's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
MSPRV vs BFRG Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, BFRG has a market cap of 7.5M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while BFRG trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas BFRG's P/E ratio is -1.19. In terms of profitability, MSPRV's ROE is N/A, compared to BFRG's ROE of -2.18%. Regarding short-term risk, MSPRV is more volatile compared to BFRG. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check BFRG's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
MSPRV vs SCNX Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, SCNX has a market cap of 6M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while SCNX trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas SCNX's P/E ratio is -0.15. In terms of profitability, MSPRV's ROE is N/A, compared to SCNX's ROE of -0.00%. Regarding short-term risk, MSPRV is more volatile compared to SCNX. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check SCNX's competition here
UpHealth, Inc. (NYSE: UPH-WT)
MSPRV vs UPH-WT Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, MSPRV's ROE is N/A, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, MSPRV is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for MSPRV.Check UPH-WT's competition here
UpHealth, Inc. (NYSE: UPH)
MSPRV vs UPH Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas UPH's P/E ratio is -0.07. In terms of profitability, MSPRV's ROE is N/A, compared to UPH's ROE of -1.05%. Regarding short-term risk, MSPRV is more volatile compared to UPH. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check UPH's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
MSPRV vs MGRX Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, MGRX has a market cap of 4.8M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while MGRX trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas MGRX's P/E ratio is -0.35. In terms of profitability, MSPRV's ROE is N/A, compared to MGRX's ROE of -1.21%. Regarding short-term risk, MSPRV is more volatile compared to MGRX. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check MGRX's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
MSPRV vs PEAR Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas PEAR's P/E ratio is -0.08. In terms of profitability, MSPRV's ROE is N/A, compared to PEAR's ROE of -0.39%. Regarding short-term risk, MSPRV is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for MSPRV.Check PEAR's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
MSPRV vs PEARW Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas PEARW's P/E ratio is -0.00. In terms of profitability, MSPRV's ROE is N/A, compared to PEARW's ROE of -0.39%. Regarding short-term risk, MSPRV is more volatile compared to PEARW. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check PEARW's competition here
Ontrak, Inc. (NASDAQ: OTRK)
MSPRV vs OTRK Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas OTRK's P/E ratio is -0.02. In terms of profitability, MSPRV's ROE is N/A, compared to OTRK's ROE of -2.11%. Regarding short-term risk, MSPRV is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check OTRK's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
MSPRV vs HCTI Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, HCTI has a market cap of 2M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while HCTI trades at $1.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas HCTI's P/E ratio is -0.22. In terms of profitability, MSPRV's ROE is N/A, compared to HCTI's ROE of -0.68%. Regarding short-term risk, MSPRV is more volatile compared to HCTI. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check HCTI's competition here
CareMax, Inc. (NASDAQ: CMAX)
MSPRV vs CMAX Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas CMAX's P/E ratio is -0.00. In terms of profitability, MSPRV's ROE is N/A, compared to CMAX's ROE of -2.01%. Regarding short-term risk, MSPRV is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check CMAX's competition here
VSee Health, Inc. (NASDAQ: VSEE)
MSPRV vs VSEE Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, VSEE has a market cap of 1.5M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while VSEE trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas VSEE's P/E ratio is -0.17. In terms of profitability, MSPRV's ROE is N/A, compared to VSEE's ROE of -115.71%. Regarding short-term risk, MSPRV is more volatile compared to VSEE. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check VSEE's competition here
Aclarion, Inc. (NASDAQ: ACON)
MSPRV vs ACON Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, ACON has a market cap of 1.4M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while ACON trades at $2.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas ACON's P/E ratio is -0.24. In terms of profitability, MSPRV's ROE is N/A, compared to ACON's ROE of -0.54%. Regarding short-term risk, MSPRV is more volatile compared to ACON. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check ACON's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
MSPRV vs LIFWZ Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, MSPRV's ROE is N/A, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, MSPRV is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check LIFWZ's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
MSPRV vs VSEEW Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, VSEEW has a market cap of 1.2M. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, MSPRV's ROE is N/A, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, MSPRV is more volatile compared to VSEEW. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check VSEEW's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
MSPRV vs EUDAW Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, EUDAW has a market cap of 926.3K. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while EUDAW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas EUDAW's P/E ratio is 0.03. In terms of profitability, MSPRV's ROE is N/A, compared to EUDAW's ROE of +0.70%. Regarding short-term risk, MSPRV is more volatile compared to EUDAW. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check EUDAW's competition here
SCWorx Corp. (NASDAQ: WORX)
MSPRV vs WORX Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, WORX has a market cap of 602.8K. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while WORX trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas WORX's P/E ratio is -0.66. In terms of profitability, MSPRV's ROE is N/A, compared to WORX's ROE of -0.65%. Regarding short-term risk, MSPRV is more volatile compared to WORX. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check WORX's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
MSPRV vs MSPRZ Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, MSPRV's ROE is N/A, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, MSPRV is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for MSPRV.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERNW)
MSPRV vs KERNW Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas KERNW's P/E ratio is -0.00. In terms of profitability, MSPRV's ROE is N/A, compared to KERNW's ROE of -0.17%. Regarding short-term risk, MSPRV is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for MSPRV.Check KERNW's competition here
Akerna Corp. (NASDAQ: KERN)
MSPRV vs KERN Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas KERN's P/E ratio is -0.01. In terms of profitability, MSPRV's ROE is N/A, compared to KERN's ROE of -0.17%. Regarding short-term risk, MSPRV is more volatile compared to KERN. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check KERN's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
MSPRV vs LIFWW Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas LIFWW's P/E ratio is N/A. In terms of profitability, MSPRV's ROE is N/A, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, MSPRV is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check LIFWW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
MSPRV vs ZCMD Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, ZCMD has a market cap of 51.1K. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while ZCMD trades at $1.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas ZCMD's P/E ratio is -0.05. In terms of profitability, MSPRV's ROE is N/A, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, MSPRV is more volatile compared to ZCMD. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check ZCMD's competition here
CareMax, Inc. (NASDAQ: CMAXW)
MSPRV vs CMAXW Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas CMAXW's P/E ratio is N/A. In terms of profitability, MSPRV's ROE is N/A, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, MSPRV is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check CMAXW's competition here
Aclarion, Inc. (NASDAQ: ACONW)
MSPRV vs ACONW Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, ACONW has a market cap of 11.2K. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while ACONW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas ACONW's P/E ratio is N/A. In terms of profitability, MSPRV's ROE is N/A, compared to ACONW's ROE of -0.54%. Regarding short-term risk, MSPRV is more volatile compared to ACONW. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check ACONW's competition here
Cerner Corporation (NASDAQ: CERN)
MSPRV vs CERN Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, CERN has a market cap of 0. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas CERN's P/E ratio is 55.84. In terms of profitability, MSPRV's ROE is N/A, compared to CERN's ROE of +0.14%. Regarding short-term risk, MSPRV is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check CERN's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
MSPRV vs AFFX Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, AFFX has a market cap of 0. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas AFFX's P/E ratio is N/A. In terms of profitability, MSPRV's ROE is N/A, compared to AFFX's ROE of +0.03%. Regarding short-term risk, MSPRV is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check AFFX's competition here
Sema4 Holdings Corp. (NASDAQ: SMFRW)
MSPRV vs SMFRW Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas SMFRW's P/E ratio is N/A. In terms of profitability, MSPRV's ROE is N/A, compared to SMFRW's ROE of -0.28%. Regarding short-term risk, MSPRV is more volatile compared to SMFRW. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check SMFRW's competition here
Cue Health Inc. (NASDAQ: HLTH)
MSPRV vs HLTH Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, HLTH has a market cap of 0. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while HLTH trades at $25.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas HLTH's P/E ratio is N/A. In terms of profitability, MSPRV's ROE is N/A, compared to HLTH's ROE of +0.00%. Regarding short-term risk, MSPRV is more volatile compared to HLTH. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check HLTH's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
MSPRV vs MTBCO Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas MTBCO's P/E ratio is N/A. In terms of profitability, MSPRV's ROE is N/A, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, MSPRV is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check MTBCO's competition here
Castlight Health, Inc. (NYSE: CSLT)
MSPRV vs CSLT Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, CSLT has a market cap of 0. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas CSLT's P/E ratio is -37.27. In terms of profitability, MSPRV's ROE is N/A, compared to CSLT's ROE of -0.42%. Regarding short-term risk, MSPRV is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check CSLT's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
MSPRV vs NAVA Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, NAVA has a market cap of 0. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas NAVA's P/E ratio is N/A. In terms of profitability, MSPRV's ROE is N/A, compared to NAVA's ROE of +0.15%. Regarding short-term risk, MSPRV is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for MSPRV.Check NAVA's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
MSPRV vs CNVY Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, CNVY has a market cap of 0. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas CNVY's P/E ratio is -71.50. In terms of profitability, MSPRV's ROE is N/A, compared to CNVY's ROE of -0.02%. Regarding short-term risk, MSPRV is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check CNVY's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
MSPRV vs MTBCP Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas MTBCP's P/E ratio is N/A. In terms of profitability, MSPRV's ROE is N/A, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, MSPRV is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check MTBCP's competition here
CareCloud, Inc. (NASDAQ: MTBC)
MSPRV vs MTBC Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, MTBC has a market cap of 0. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas MTBC's P/E ratio is N/A. In terms of profitability, MSPRV's ROE is N/A, compared to MTBC's ROE of +0.17%. Regarding short-term risk, MSPRV is more volatile compared to MTBC. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check MTBC's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
MSPRV vs CHNG Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRV stands at 0. In comparison, CHNG has a market cap of 0. Regarding current trading prices, MSPRV is priced at $0.07 on the NASDAQ, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRV currently has a P/E ratio of N/A, whereas CHNG's P/E ratio is -152.72. In terms of profitability, MSPRV's ROE is N/A, compared to CHNG's ROE of -0.05%. Regarding short-term risk, MSPRV is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for MSPRV.Check CHNG's competition here